Paper41907375
Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy.
Wang F and 12 others. Int J Nanomedicine, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy. Papers, record 41907375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41907375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Immunotherapy | Major topic |
| Nanomedicine | Major topic |
| Humans | |
| Animals | |
| Combined Modality Therapy | |
| Tumor Microenvironment | |
| Precision Medicine | |
| Photochemotherapy |
Source PubMed
References202
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37790250 | Drug-loaded hybrid hydrogels for sonodynamic-chemodyanmic therapy and tumor metastasis suppression. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37790250 | PubMed |
| 2 | 38193125 | Curcumin/L-OHP co-loaded HAP for cGAS-STING pathway activation to enhance the natural immune response in colorectal cancer. | Bioeng Transl Med | 2024 | https://conductscience.org/library/papers/38193125 | PubMed |
| 3 | 37500633 | Enrichment and sensing tumor cells by embedded immunomodulatory DNA hydrogel to inhibit postoperative tumor recurrence. | Nat Commun | 2023 | https://conductscience.org/library/papers/37500633 | PubMed |
| 4 | 35516575 | Photodynamic diagnosis and photodynamic therapy of colorectal cancer in vitro and in vivo. | RSC Adv | 2020 | https://conductscience.org/library/papers/35516575 | PubMed |
| 5 | 34374945 | High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications. | Ann Biomed Eng | 2021 | https://conductscience.org/library/papers/34374945 | PubMed |
| 6 | 33565157 | Emerging Nanomedicine-Enabled/Enhanced Nanodynamic Therapies beyond Traditional Photodynamics. | Adv Mater | 2021 | https://conductscience.org/library/papers/33565157 | PubMed |
| 7 | 40647563 | Establishment of an Orthotopic and Metastatic Colorectal Cancer Mouse Model Using a Tissue Adhesive-Based Implantation Method. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647563 | PubMed |
| 8 | 36277384 | Hydrogen sulfide activatable metal-organic frameworks for Fluorescence Imaging-Guided Photodynamic Therapy of colorectal cancer. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36277384 | PubMed |
| 9 | 36703964 | Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36703964 | PubMed |
| 10 | 39163944 | Tumor cell loaded thermosensitive hydrogel for photodynamic therapy associated tumor antigens release. | Biochim Biophys Acta Gen Subj | 2024 | https://conductscience.org/library/papers/39163944 | PubMed |
| 11 | 39838815 | A Sustained H2/Fluorouracil-Releasing Suppository for High-efficacy and Low-Toxicity Hydrogenochemotherapy of Colon Cancer. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/39838815 | PubMed |
| 12 | 33613470 | Reactive Oxygen Species in Pathogen Clearance: The Killing Mechanisms, the Adaption Response, and the Side Effects. | Front Microbiol | 2020 | https://conductscience.org/library/papers/33613470 | PubMed |
| 13 | 40948965 | Focused ultrasound in modern medicine: bioengineering interfaces, molecular effects, and clinical breakthroughs. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40948965 | PubMed |
| 14 | 31842994 | Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31842994 | PubMed |
| 15 | 36442821 | Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy. | Acta Biomater | 2023 | https://conductscience.org/library/papers/36442821 | PubMed |
| 16 | 33916823 | Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications. | Molecules | 2021 | https://conductscience.org/library/papers/33916823 | PubMed |
| 17 | 37806376 | Injectable hydrogels for personalized cancer immunotherapies. | Acta Biomater | 2023 | https://conductscience.org/library/papers/37806376 | PubMed |
| 18 | 35427471 | Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/35427471 | PubMed |
| 19 | 31681729 | Injectable Hydrogels for Localized Cancer Therapy. | Front Chem | 2019 | https://conductscience.org/library/papers/31681729 | PubMed |
| 20 | 38353760 | Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/38353760 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41907375
GET https://conductscience.org/api/papers/v1/41907375/references?page=2